C. Kallenberg

发表

Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjogren's syndrome.

A. Vissink, J. Roodenburg, C. Kallenberg, 2007, Rheumatology.

Sialometry and sialochemistry: diagnostic tools for Sjögren's syndrome

A. Vissink, H. Bootsma, F. Spijkervet, 2001, Annals of the rheumatic diseases.

Anti-cytoplasmatic antibody in Wegener's granulomatosis.

C. Kallenberg, J. Tervaert, 1987, The American review of respiratory disease.

EULAR recommendations for the management of primary small and medium vessel vasculitis

H. Raspe, P. Merkel, C. Kallenberg, 2008, Annals of the Rheumatic Diseases.

Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases

C. Kallenberg, P. Limburg, J. Kleibeuker, 1993, Hepatology.

Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane-mediated glomerular injury in the rat.

C. Kallenberg, P. Heeringa, J. van den Born, 1996, The American journal of pathology.

EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints

J. Ioannidis, C. Gordon, D. Isenberg, 2008, Annals of the rheumatic diseases.

Leukocyte activation in sepsis; correlations with disease state and mortality

C. Kallenberg, J. Hermans, J. Zijlstra, 2000, Intensive Care Medicine.

of primary small and medium vessel vasculitis EULAR recommendations for the management

H. Raspe, D. Scott, R. Luqmani, 2009 .

Is Wegener's granulomatosis an autoimmune disease?

C. Kallenberg, C. Savage, C. Kallenberg, 2000, Current opinion in rheumatology.

Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential.

C. Kallenberg, E. Brouwer, J. Weening, 1994, Kidney international.

Immunoglobulin genes, HLA-B8/DR3, and immune responsiveness to primary immunogen and mitogens in normal subjects.

T. Ockhuizen, J. Westra, R. Klaassen, 1988, Clinical immunology and immunopathology.

Antimyeloperoxidase-associated lung disease. An experimental model.

C. Kallenberg, P. Heeringa, E. Brouwer, 1999, American journal of respiratory and critical care medicine.

Expression of iNOS, eNOS, and peroxynitrite-modified proteins in experimental anti-myeloperoxidase associated crescentic glomerulonephritis.

C. Kallenberg, P. Heeringa, H. van Goor, 1996, Kidney international.

Renal ischemia/reperfusion injury contributes to renal damage in experimental anti-myeloperoxidase-associated proliferative glomerulonephritis.

E. Brouwer, C. Kallenberg, M. Huitema, 1995, Kidney international.

EULAR recommendations for the management of large vessel vasculitis

H. Raspe, P. Merkel, C. Kallenberg, 2008, Annals of the rheumatic diseases.

High mobility group box1 (HMGB1) in relation to cutaneous inflammation in systemic lupus erythematosus (SLE)

E. Reefman, M. Bijl, J. Westra, 2013, Lupus.

Receptor for advanced glycation end products (RAGE) polymorphisms are associated with systemic lupus erythematosus and disease severity in lupus nephritis

M. Bijl, C. Kallenberg, I. Nolte, 2012, Lupus.

Lack of Association of C-C Chemokine Receptor 5 Δ32 Deletion Status with Rheumatoid Arthritis, Systemic Lupus Erythematosus, Lupus Nephritis, and Disease Severity

C. Kallenberg, G. Navis, M. Bijl, 2010, The Journal of Rheumatology.

Familial Occurrence of Autoimmune Diseases and Autoantibodies in a Caucasian Population of Patients with Systemic Lupus Erythematosus

M. Bijl, C. Kallenberg, S. Corporaal, 2002, Clinical Rheumatology.

Tubular dysfunction in proliferative lupus nephritis.

P. D. de Jong, C. Kallenberg, E. Ter Borg, 1991, American journal of nephrology.

Hydroxychloroquine treatment for primary Sjögren's syndrome: a two year double blind crossover trial.

A. van der Heide, J. Bijlsma, R. Hené, 1993, Annals of the rheumatic diseases.

of large vessel vasculitis EULAR recommendations for the management

H. Raspe, D. Scott, R. Luqmani, 2009 .

Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study.

P. Limburg, C. Kallenberg, G. Horst, 1990, Arthritis and rheumatism.

Infections, connective tissue diseases and vasculitis.

A. Tincani, A. Doria, C. Kallenberg, 2008, Clinical and experimental rheumatology.

Laboratory tests as predictors of flares in systemic lupus erythematosus: comment on the article by Esdaile et al.

H. Bootsma, P. Spronk, C. Kallenberg, 1997, Arthritis and rheumatism.

Changes in levels of antibodies against the 70 kDa and a polypeptides of the U1RNP complex in relation to exacerbations of systemic lupus erythematosus.

W. V. van Venrooij, P. Limburg, C. Kallenberg, 1991, The Journal of rheumatology.

Changes in plasma levels of interleukin‐2 receptor in relation to disease exacerbations and levels of anti‐dsDNA and complement in systemic lupus erythematosus

P. Limburg, C. Kallenberg, G. Horst, 1990, Clinical and experimental immunology.

EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs

J. Ioannidis, I. Bruce, M. van Buchem, 2010, Annals of the rheumatic diseases.

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics

J. Ioannidis, C. Gordon, D. Isenberg, 2007, Annals of the rheumatic diseases.

Rises in anti-double stranded DNA antibody levels prior to exacerbations of systemic lupus erythematosus are not merely due to polyclonal B cell activation.

C. Kallenberg, P. Limburg, C. Kallenberg, 1991, Clinical immunology and immunopathology.

Proteinase 3, Wegener’s autoantigen: from gene to antigen

P. Limburg, C. Kallenberg, C. Kallenberg, 2001, Journal of leukocyte biology.

C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study.

P. Limburg, M. V. van Rijswijk, C. Kallenberg, 1990, The Journal of rheumatology.

Antimyeloperoxidase-associated proliferative glomerulonephritis: an animal model

C. Kallenberg, E. Brouwer, J. Weening, 1993, The Journal of experimental medicine.

Fcgamma receptor polymorphisms in systemic lupus erythematosus: association with disease and in vivo clearance of immune complexes.

M. Bijl, W. Sluiter, C. Kallenberg, 2000, Arthritis and rheumatism.

Prospective multicentre trial on the short-term effects of plasma exchange versus cytotoxic drugs in steroid-resistant lupus nephritis.

R. Hené, C. Kallenberg, R. Valentijn, 1988, The Netherlands journal of medicine.

ANCA—pathophysiology revisited

E. Brouwer, J. Weening, C. Kallenberg, 1995, Clinical and experimental immunology.

Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases.

R. van Wijk, C. Kallenberg, P. Limburg, 2000, Journal of hepatology.

In vitro up-regulation of E-selectin and induction of interleukin-6 in endothelial cells by autoantibodies in Wegener's granulomatosis and microscopic polyangiitis.

R. van Wijk, J. Willem, G. Molema, 1999, Clinical and experimental rheumatology.

Neutrophil activation in vitro and in vivo in Wegener's granulomatosis.

C. Kallenberg, P. Heeringa, H. van Goor, 1994, Kidney international.

Detection of autoantibodies to ribonucleoproteins by counter-immunoelectropheresis, immunoblotting and RNA-immunoprecipitation: comparison of results.

P. Limburg, D. Jaarsma, C. Kallenberg, 1990, Clinical and experimental rheumatology.

Leucocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis.

A. M. Muller Kobold, C. Kallenberg, J. Tervaert, 1998, British journal of rheumatology.

Wegener’s granulomatosis patients show an adequate antibody response to influenza vaccination

C. Kallenberg, M. Bijl, J. Wilschut, 2008, Annals of the rheumatic diseases.

Anti‐neutrophil cytoplasmic antibodies and the endothelium: many ways to vasculitis

C. Kallenberg, C. Kallenberg, 1997, European journal of clinical investigation.

HMGB1 in vascular diseases: Its role in vascular inflammation and atherosclerosis.

P. Limburg, M. Bijl, J. Westra, 2012, Autoimmunity reviews.

Effects of smoking on activation markers, Fas expression and apoptosis of peripheral blood lymphocytes

P. Limburg, M. Bijl, C. Kallenberg, 2001, European journal of clinical investigation.

Patients with systemic lupus erythematosus and Jaccoud's arthropathy: a clinical subset with an increased C reactive protein response?

P. Spronk, C. Kallenberg, E. Ter Borg, 1992, Annals of the rheumatic diseases.

Nucleosomes and histones are present in glomerular deposits in human lupus nephritis.

J. van den Born, M. Monestier, C. Kallenberg, 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Connective tissue disease in patients presenting with Raynaud's phenomenon alone.

C. Kallenberg, 1991, Annals of the rheumatic diseases.

Early detection of connective tissue disease in patients with Raynaud's phenomenon.

C. Kallenberg, Cornelis Kallenberg, 1990, Rheumatic diseases clinics of North America.

Autoimmunity to lysosomal enzymes: new clues to vasculitis and glomerulonephritis?

R. Goldschmeding, J. Weening, C. Kallenberg, 1991, Immunology today.

Elastase, but not proteinase 3 (PR3), induces proteinuria associated with loss of glomerular basement membrane heparan sulphate after in vivo renal perfusion in rats

P. Heeringa, J. van den Born, K. Dolman, 1996, Clinical and experimental immunology.

The antiphospholipid syndrome II

M. Bijl, C. Kallenberg, 2004 .

The central role of monocytes in the pathogenesis of sepsis: consequences for immunomonitoring and treatment.

A. M. Muller Kobold, T. The, C. Kallenberg, 1999, The Netherlands journal of medicine.

HMGB1 in systemic lupus Erythematosus: Its role in cutaneous lesions development.

P. Limburg, M. Bijl, J. Westra, 2010, Autoimmunity reviews.

Shifts of anti-Sm-specific antibodies in patients with systemic lupus erythematosus: analysis by counter-immunoelectrophoresis, immunoblotting and RNA-immunoprecipitation.

P. Limburg, C. Kallenberg, G. Horst, 1991, Journal of autoimmunity.

Arteritis of both carotid arteries in a patient with focal, crescentic glomerulonephritis and anti-neutrophil cytoplasmic autoantibodies.

C. Kallenberg, B. Rozman, D. Logar, 1994, British journal of rheumatology.

The pathogenesis of vasculitis

C. Kallenberg, 1998, Lupus.

Criteria for disease activity in Wegener's granulomatosis: A requirement for longitudinal clinical studies

C. Kallenberg, C. Stegeman, J. Tervaert, 1990, APMIS. Supplementum.

Decreased filtration fraction during active proliferative lupus nephritis: relation to disease activity and reversibility of renal function.

P. D. de Jong, C. Kallenberg, A. Donker, 1984, Clinical nephrology.

Does analysis of the antigenic specificities of anti-neutrophil cytoplasmic antibodies contribute to their clinical significance in the inflammatory bowel diseases?

P. Limburg, J. Kleibeuker, C. Kallenberg, 1999, Scandinavian journal of gastroenterology.

Antineutrophil cytoplasmic antibodies in rheumatoid arthritis. Characterization and clinical correlations.

M. V. van Leeuwen, P. Limburg, C. Kallenberg, 1993, Arthritis and rheumatism.

Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders.

C. Kallenberg, C. Kallenberg, J. Tervaert, 1992, The American journal of medicine.

Role of CCR5 Δ32 bp deletion in RA and SLE

M. Bijl, C. Kallenberg, H. Martens, 2009, Autoimmunity.

Cell adhesion molecules in vasculitis.

J. C. Cohen Tervaert, C. Kallenberg, J. Tervaert, 1997, Current opinion in rheumatology.

Anti-neutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel disease (IBD)

J. C. Cohen Tervaert, C. Kallenberg, J. Broekroelofs, 1994, Digestive Diseases and Sciences.

Transient arthritis with positive tests for rheumatoid factor as presenting sign of shunt nephritis.

M. V. van Rijswijk, C. Kallenberg, E. Ter Borg, 1991, Annals of the rheumatic diseases.

Treatment of primary Sjögren's syndrome with D-penicillamine: a pilot study.

C. Kallenberg, H. Haanen, J. Kerckhaert, 2002, The Netherlands journal of medicine.

Influence of ageing on antibody formation in vivo after immunisation with the primary T-cell dependent antigen Helix pomatia haemocyanin

C. Kallenberg, E. Remarque, W. Hijmans, 1992, Mechanisms of Ageing and Development.

Antinuclear antibody (ANA) substrates and quantification techniques

C. Kallenberg, P. Limburg, 1987, Clinical Rheumatology.

Neurologic manifestations of systemic vasculitides.

C. Kallenberg, J. Tervaert, 1993, Rheumatic diseases clinics of North America.

Skin sensitivity to UVB irradiation in systemic lupus erythematosus is not related to the level of apoptosis induction in keratinocytes.

E. Reefman, P. Limburg, M. Bijl, 2006, Rheumatology.

SYSTEMIC LUPUS ERYTHEMATOSUS ( SLE ) : the role of apoptosis

C. Kallenberg, P. Limburg, M. Bijl, 2001 .

Treatment of severe thrombocytopenia in systemic lupus erythematosus with intravenous gammaglobulin.

C. Kallenberg, E. Ter Borg, 1992, Annals of the rheumatic diseases.

Levels of soluble VCAM‐1, soluble ICAM‐1, and soluble E‐selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study

C. Kallenberg, P. Limburg, H. Bootsma, 1994, Clinical and experimental immunology.

Sialometry and sialochemistry: a non-invasive approach for diagnosing Sjögren's syndrome

W W I Kalk, A Vissink, B Stegenga, 2002, Annals of the rheumatic diseases.

SALIVARY GLAND FUNCTION 55 A I A NEW SCREENING DEVICE : DETECTION OF SJÖGREN ’ S SYNDROME ON A DROPLET SALIVA

A. Vissink, J. Roodenburg, B. Stegenga, 2018 .

S I SIALOMETRY AND SIALOCHEMISTRY : DIAGNOSTIC TOOLS IN SJÖGREN ’ S SYNDROME

A. Vissink, H. Bootsma, F. Spijkervet, 2001 .

The measurement of serum salivary isoamylase as a clinical parameter in Sjögren's syndrome.

A. Vissink, J. Roodenburg, H. Bootsma, 2002, Rheumatology.

SALIVARY ENZYME IN SERUM 63 T I THE PERFORMANCE OF SERUM SALIVARY ISOAMYLASE AS A CLINICAL PARAMETER IN SJÖGREN ’ S SYNDROME

A. Vissink, H. Bootsma, F. Spijkervet, 2001 .

In vitro T lymphocyte responses to proteinase 3 (PR3) and linear peptides of PR3 in patients with Wegener's granulomatosis (WG)

P. Limburg, C. Franssen, R. van der Zee, 2000, Clinical and experimental immunology.

Patients with systemic lupus erythematosus with high plasma levels of sFas risk relapse.

C. Kallenberg, M. Bijl, A. Creasy, 1999, The Journal of rheumatology.

Sequential development of antibodies to specific Sm polypeptides in a patient with systemic lupus erythematosus: evidence for independent regulation of anti-double-stranded DNA and anti-Sm antibody production.

P. Limburg, D. Jaarsma, C. Kallenberg, 1988, Arthritis and rheumatism.

Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity

I. Nolte, A. D. De Lange, M. Bijl, 2008, Annals of the rheumatic diseases.

Imbalances of T-cells in thymoma-associated hypogammaglobulinaemia.

S. Poppema, M. van der Giessen, C. Kallenberg, 1986, The Netherlands journal of medicine.

Are antineutrophil cytoplasmic antibody-associated vasculitides pauci-immune?

C. Kallenberg, C. Kallenberg, J. Tervaert, 2001, Rheumatic diseases clinics of North America.

Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus

P. Limburg, M. Bijl, C. Kallenberg, 2001, Annals of the rheumatic diseases.

Vascular responsiveness in the microcirculation of patients with systemic lupus erythematosus is not impaired

M. Bijl, A. Smit, C. Kallenberg, 2008, Lupus.

Opposed independent effects and epistasis in the complex association of IRF5 to SLE

M. Calaza, J. Gómez-Reino, R. Scorza, 2007, Genes and Immunity.

Anti‐neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlates

C. Kallenberg, J. Broekroelofs, P C Limburg, 1994, Clinical and experimental immunology.

Anti-neutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel disease (IBD). Relation to disease pattern and disease activity.

C. Kallenberg, J. Tervaert, J. Broekroelofs, 1994, Digestive diseases and sciences.

Fas expression on peripheral blood lymphocytes in systemic lupus erythematosus (SLE): relation to lymphocyte activation and disease activity

P. Limburg, M. Bijl, C. Kallenberg, 2001, Lupus.

IgG subclass distribution of autoantibodies differs between renal and extra-renal relapses in patients with systemic lupus erythematosus.

C. Kallenberg, M. Bijl, H. Bootsma, 2002, Rheumatology.

An extensive screen of the HLA region reveals an independent association of HLA class I and class II with susceptibility for systemic lupus erythematosus

G. T. te Meerman, I. Nolte, M. Bijl, 2009, Scandinavian journal of rheumatology.

Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement

E. Reefman, M. Bijl, C. Kallenberg, 2005, Annals of the rheumatic diseases.

Anti-neutrophil cytoplasmic antibodies in giant cell arteritis and polymyalgia rheumatica.

R. van Wijk, P. Limburg, C. Kallenberg, 1993, Advances in experimental medicine and biology.

Beneath the surface.

A. Diepstra, C. Kallenberg, J. Koornstra, 2002, The American journal of medicine.

Autoantibodies to myeloid lysosomal enzymes: new clues to vasculitis and glomerulonephritis. A hypothesis based on humoral immune mechanisms.

R. Goldschmeding, C. Kallenberg, A. von dem Borne, 1990, The Netherlands journal of medicine.

Diversity of antigens recognized by ANCA--is this of clinical relevance?

C. Kallenberg, 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Pathophysiology of ANCA-associated glomerulonephritis.

P. Limburg, A. M. Muller Kobold, C. Kallenberg, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Autoantibodies in vasculitis: current perspectives.

C. Kallenberg, 1993, Clinical and experimental rheumatology.

AA amyloidosis associated with systemic lupus erythematosus

P. Jong, C. Kallenberg, M. H. Rijswijk, 2004, Rheumatology International.

Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts.

R. Graaff, M. Bijl, A. Smit, 2008, Rheumatology.

Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus.

A. Smit, C. Kallenberg, R. Graaff, 2006, Rheumatology.

TherapeuticsClinical Studies Including Force of the EULAR Standing Committee for systemic lupus erythematosus. Report of a Task EULAR recommendations for the management of

J. Ioannidis, C. Gordon, D. Isenberg, 2008 .

CHAPTER 2 HMGB 1 in vascular diseases : Its role in vascular inflammation and atherosclerosis

M. Bijl, J. Westra, C. Kallenberg, 2017 .